Inactive Instrument

News pSivida Corp. Nasdaq

Equities

US74440J1016

Summary

Unlock all the news: Be the first to know and act before the market!

PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle	16-08-09	PU
PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve	16-07-14	PU
PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe	16-05-02	PU
PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs	15-09-28	BU
PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015	15-09-14	BU
PSivida : Provides Company Update and Reports Fourth Quarter and FY 2015 Results	15-09-09	BU
PSivida : CEO Invited to Speak at Surfaces in BioMaterials Foundation's BioInterface 2015 Annual Symposium	15-09-03	PU
PSivida : CEO Invited to Speak at Surfaces in BioMaterials Foundation’s BioInterface 2015 Annual Symposium	15-09-03	BU
PSivida : Announces Fourth Quarter and Fiscal Year 2015 Financial Results Release Date and Conference Call Information	15-09-02	BU
PSivida : CEO to Speak at Controlled Release Society Annual Meeting Workshop in Edinburgh, Scotland, This Weekend	15-07-21	BU
PSivida : Announces Positive Top Line Results From Investigator-Sponsored Phase II Study of Medidur™ for Uveitis	15-07-13	BU
PSivida : Announces Top-Line Results from Investigator-Sponsored Phase II Study of Medidur™ for Uveitis to Be Reported Next Week	15-07-07	BU
PSivida : CEO to Present at ISOPT Clinical Meeting in Berlin in July 2015	15-06-24	BU
PSivida : Reports Positive IOP Safety Data in Phase III Trial of Medidur™ for Posterior Uveitis	15-05-19	BU
PSivida : Announces Two Tech Evaluation Agreements with Leading Global Pharmaceutical Company	15-05-12	BU
PSivida : Reports Third Quarter FY 2015 Results	15-05-08	BU
PSivida : Announces Third Quarter Fiscal Year 2015 Financial Results Release Date and Conference Call Information	15-05-01	BU
PSivida : Reports ILUVIEN® for DME Approved in Poland	15-04-18	PU
PSivida : Reports ILUVIEN® for DME Approved in Poland	15-04-14	BU
PSivida : Completes Targeted Enrollment of Phase III Trial of Medidur™ for Posterior Uveitis	15-03-26	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News pSivida Corp. Nasdaq

Equities

US74440J1016

Summary

Filters